Subscribe
Magazine
Past Issues
Surveys
Industry Statistics
About Us
Members Only
Best Places to Work
General Interest
Exploration & Development
Drilling & Production
Refining & Processing
Pipelines & Transportation
LNG
Energy Transition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Onconova Therapeutic
(NQ:
ONTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
0.9100 (100)
Ask (Size)
1.020 (1)
Prev. Close
0.9953
Today's Range
N/A - N/A
52wk Range
0.5509 - 1.100
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Traws Pharma Announces New Employee Inducement Grants
April 02, 2024
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Announce Business Combination to Form Traws Pharma, Inc, a Best-in-Class Virology and Oncology Company
April 02, 2024
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
Performance
More News
Read More
Onconova Therapeutics’ Rigosertib Poster Selected for AACR 2024
March 08, 2024
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
Onconova Therapeutics's Earnings: A Preview
November 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 15, 2024
Via
Benzinga
Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
December 12, 2023
Via
Benzinga
Onconova Therapeutics’ Narazaciclib ASH Poster Highlights Activity in Treatment Resistant Mantle Cell Lymphoma
December 12, 2023
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
December 11, 2023
Via
Benzinga
Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session
December 11, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 11, 2023
Via
Benzinga
Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket
December 11, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
December 11, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
December 08, 2023
Via
Benzinga
Onconova Therapeutics’ Preclinical Narazaciclib Data at SABCS Highlights Differentiated Anti-Tumor Activity v. Other CDK4/6i’s
December 08, 2023
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
Onconova Therapeutics to Present at NobleCon19, Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference
November 28, 2023
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
Onconova Therapeutics Reports Corporate Update and Announces Third Quarter 2023 Financial Results
November 14, 2023
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
Onconova Therapeutics to Provide Corporate Update and Announce Third Quarter 2023 Financial Results on November 14, 2023
November 07, 2023
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
Onconova Therapeutics’ ASH Poster To Focus on Narazaciclib in MCL
November 02, 2023
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 31, 2023
Via
Benzinga
Onconova Expands Leadership Team with Two Key Appointments
October 24, 2023
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
Promising Preclinical Narazaciclib Data Presented at MCL Meeting
October 19, 2023
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
Encouraging Rigosertib Data Presented at EADV as Late Breaker
October 12, 2023
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 11, 2023
Via
Benzinga
Onconova Therapeutics to Present a Late-Breaking Abstract on Rigosertib at the 2023 EADV Congress
September 28, 2023
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
Onconova Therapeutics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference
September 06, 2023
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.